Skip to content

Clinical trials

Phase 3 Melanoma trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Phase: Phase 3 Country / region: South Korea Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20111
20121
20132
20141
20151
20161
20171
20191
20211
20235
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated5
Active, not recruiting3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
Merck Sharp & Dohme LLC3
Hoffmann-La Roche2
Pfizer2
Bristol-Myers Squibb1
Eli Lilly and Company1
GlaxoSmithKline1
HUYABIO International, LLC.1
Incyte Corporation1
Iovance Biotherapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma18
Neoplasm Metastasis3
Skin Neoplasms3
Neoplasms2
Skin Diseases2
Brain Neoplasms1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.